Publication | Closed Access

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesParallel Treatment TrialImmunologyInflammatory Rheumatic DiseasePharmacotherapyPsoriatic ArthritisMethotrexate MonotherapyRheumatoid Arthritis